Holen Sie sich die Stockscreener-App
5.16
5.52%
0.27
Handel nachbörslich:
5.16
Schlusskurs vom Vortag:
$4.89
Offen:
$5
24-Stunden-Volumen:
676.17K
Relative Volume:
0.88
Marktkapitalisierung:
$207.91M
Einnahmen:
$121.14M
Nettoeinkommen (Verlust:
$-32.33M
KGV:
-6.00
EPS:
-0.86
Netto-Cashflow:
$-22.69M
1W Leistung:
-3.73%
1M Leistung:
-28.53%
6M Leistung:
-58.79%
1J Leistung:
-68.34%
1-Tages-Spanne:
$4.97
$5.21
1-Wochen-Bereich:
$4.815
$5.46
52-Wochen-Spanne:
$4.67
$19.18
Quanterix Corp Stock (QTRX) Company Profile
Firmenname
Quanterix Corp
Sektor
Branche
Telefon
617-301-9400
Adresse
900 MIDDLESEX TURNPIKE, BILLERICA, MA
Vergleichen Sie QTRX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
QTRX
Quanterix Corp
|
5.16 | 207.91M | 121.14M | -32.33M | -22.69M | -0.86 |
|
ABT
Abbott Laboratories
|
131.73 | 218.91B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
95.05 | 139.37B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
348.12 | 134.90B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
83.37 | 106.90B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
70.60 | 41.45B | 5.72B | 4.17B | 259.90M | 6.97 |
Quanterix Corp Stock (QTRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-02-01 | Eingeleitet | Scotiabank | Sector Outperform |
| 2023-09-25 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2023-08-08 | Hochstufung | SVB Securities | Market Perform → Outperform |
| 2023-05-23 | Hochstufung | Goldman | Neutral → Buy |
| 2022-08-15 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2022-08-09 | Herabstufung | Cowen | Outperform → Market Perform |
| 2022-08-09 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2022-03-02 | Hochstufung | Goldman | Sell → Neutral |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-06-04 | Eingeleitet | Goldman | Sell |
Alle ansehen
Quanterix Corp Aktie (QTRX) Neueste Nachrichten
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RKDA, CKPT, QTRX on Behalf of Shareholders - marketscreener.com
QUANTERIX CORP : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Change in Directors or Principal Officers (form 8-K) - marketscreener.com
Kent Lake Files Definitive Proxy Statement And Sends Letter To Quanterix Shareholders - marketscreener.com
Kent Lake Files Definitive Proxy Statement and Sends Letter to Quanterix Shareholders - marketscreener.com
Quanterix Co. (NASDAQ:QTRX) Shares Purchased by Vanguard Group Inc. - Defense World
Tikvah Management Calls on Quanterix to Explain the Egregious Te - GuruFocus
Tikvah Management Calls on Quanterix to Explain the Egregious Terms of Convertible Notes Purchased from Akoya Biosciences - Bluefield Daily Telegraph
Quanterix Faces Investor Backlash: $30M Convertible Notes Deal Under Fire - Stock Titan
American Century Companies Inc. Grows Stock Position in Quanterix Co. (NASDAQ:QTRX) - Defense World
KLP Kapitalforvaltning AS Takes $66,000 Position in Quanterix Co. (NASDAQ:QTRX) - Defense World
53,626 Shares in Quanterix Co. (NASDAQ:QTRX) Acquired by Raymond James Financial Inc. - MarketBeat
Quanterix stock plunges to 52-week low of $4.85 amid market challenges - Investing.com
Raymond James Financial Inc. Purchases New Position in Quanterix Co. (NASDAQ:QTRX) - Defense World
Kent Lake Comments on Quanterix?s Bridge Financing for Akoya - MarketScreener
Quanterix Under Fire: Top Investor Warns of 'Value Destructive' $30M Deal with Struggling Akoya - Stock Titan
$TOCKHOLDER ALERT: The M&A Class Action Firm Urges Shareholders of FNA, BECN, QTRX, PLYA to Take Action - GlobeNewswire Inc.
Quanterix: Still Many, Many Questions - Seeking Alpha
Quanterix Showcases Innovation Powered by Simoa® at AD/PD with Customer Research and New Dried Blood Spot Extraction Kit - Yahoo Finance
Revolutionary Blood Spot Kit Makes Alzheimer's Testing More Accessible and Affordable - Stock Titan
Quanterix Co. (NASDAQ:QTRX) Sees Large Decline in Short Interest - MarketBeat
Quanterix stock plunges to 52-week low at $6.27 amid market challenges - Investing.com
Quanterix CorpOn March 24, Appointed William P. Donnelly As ChairmanSEC Filing - MarketScreener
Charles Schwab Investment Management Inc. Sells 58,989 Shares of Quanterix Co. (NASDAQ:QTRX) - Defense World
Scotiabank cuts Quanterix stock price target to $18 from $28 By Investing.com - Investing.com Australia
Quanterix (NASDAQ:QTRX) Given New $18.00 Price Target at Scotiabank - Defense World
Scotiabank cuts Quanterix stock price target to $18 from $28 - Investing.com India
Bank of New York Mellon Corp Has $1.15 Million Stake in Quanterix Co. (NASDAQ:QTRX) - Defense World
Tikvah to oppose Quanterix-Akoya Biosciences merger By Investing.com - Investing.com Australia
Tikvah to oppose Quanterix-Akoya Biosciences merger - Investing.com India
Tikvah Management Announces Intention to Vote AGAINST Quanterix’s Proposed Merger with Akoya Biosciences - Business Wire
Connor Clark & Lunn Investment Management Ltd. Cuts Holdings in Quanterix Co. (NASDAQ:QTRX) - Defense World
Key Investor Fights Back: Quanterix Merger Under Fire Over Valuation Concerns - Stock Titan
What is Leerink Partnrs’ Estimate for Quanterix Q1 Earnings? - Defense World
Quanterix Corporation (NASDAQ:QTRX) Q4 2024 Earnings Call Transcript - Insider Monkey
Quanterix Full Year 2024 Earnings: EPS Misses Expectations - Yahoo Finance
Quanterix (NASDAQ:QTRX) Price Target Cut to $15.00 by Analysts at Canaccord Genuity Group - Defense World
Canaccord cuts Quanterix stock target to $15, maintains Buy rating By Investing.com - Investing.com Australia
Quanterix stock plunges to 52-week low of $6.66 amid market challenges - Investing.com
Canaccord cuts Quanterix stock target to $15, maintains Buy rating - Investing.com India
Quanterix Corp (QTRX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid Market Challenges - Yahoo
Earnings call transcript: Quanterix Q4 2024 misses EPS forecast, stock rises - Investing.com Canada
Earnings call transcript: Quanterix Q4 2024 misses EPS forecast, stock rises By Investing.com - Investing.com South Africa
Quanterix Corp reports results for the quarter ended December 31Earnings Summary - TradingView
Quanterix sees FY25 revenue $140M-$146M, consensus $154.7M - TipRanks
Quanterix Corp SEC 10-K Report - TradingView
Kent Lake urges Quanterix to address questions regarding Akoya deal -March 17, 2025 at 04:28 pm EDT - Marketscreener.com
Quanterix Corporation Reports Seventh Consecutive Quarter of Double-Digit Revenue Growth - TradingView
Quanterix earnings missed by $0.07, revenue fell short of estimates - Investing.com
QUANTERIX Earnings Preview: Recent $QTRX Insider Trading, Hedge Fund Activity, and More - Nasdaq
Quanterix Q4 2024 Earnings: Key Financial Results Coming March 17How to Listen Live - Stock Titan
Quanterix Corp (NASDAQ: QTRX) Is Down -1.62% – Is It Capable Of A Rally? - Stocks Register
Finanzdaten der Quanterix Corp-Aktie (QTRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):